Trial · NCT01594333
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Subjects With Major Adverse Cardiovascular Events | Methotrexate | 170 | participants | ||
| Number of Subjects With Major Adverse Cardiovascular Events | Placebo | 167 | participants | ||
| Number of Subjects With Major Adverse Cardiovascular Event or Hospitalization for Unstable Angina That Led to Urgent Coronary Revascularization | Methotrexate | 201 | participants | ||
| Number of Subjects With Major Adverse Cardiovascular Event or Hospitalization for Unstable Angina That Led to Urgent Coronary Revascularization | Placebo | 207 | participants | ||
| Number of Subjects With All-cause Mortality | Methotrexate | 96 | participants | ||
| Number of Subjects With All-cause Mortality | Placebo | 83 | participants | ||
| Number of Subjects With Major Adverse Cardiovascular Event or Any Coronary Revascularization | Methotrexate | 278 | participants | ||
| Number of Subjects With Major Adverse Cardiovascular Event or Any Coronary Revascularization | Placebo | 288 | participants | ||
| Number of Subjects With Hospitalization for Congestive Heart Failure | Methotrexate | 48 | participants | ||
| Number of Subjects With Hospitalization for Congestive Heart Failure | Placebo | 53 | participants | ||
| Number of Subjects With Major Adverse Cardiovascular Event, Coronary Revascularization, Hospitalization for Congestive Heart Failure or All Cause Mortality | Methotrexate | 344 | participants | ||
| Number of Subjects With Major Adverse Cardiovascular Event, Coronary Revascularization, Hospitalization for Congestive Heart Failure or All Cause Mortality | Placebo | 345 | participants | ||
| Number of Subjects With New Onset Type 2 Diabetes | Methotrexate | 4 | Participants | ||
| Number of Subjects With New Onset Type 2 Diabetes | Placebo | 6 | Participants | ||
| Number of Subjects With Hospitalization for Unstable Angina That Led to Unplanned Coronary Revascularization | Methotrexate | 41 | participants | ||
| Number of Subjects With Hospitalization for Unstable Angina That Led to Unplanned Coronary Revascularization | Placebo | 50 | participants | ||
| Number of Subjects With Coronary Revascularization | Methotrexate | 190 | participants | ||
| Number of Subjects With Coronary Revascularization | Placebo | 205 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01594333/results